Loading clinical trials...
Loading clinical trials...
Double-Blind Placebo-Controlled Investigation of Naltrexone for Pathological Gambling
Conditions
Interventions
Naltrexone
Placebo
Locations
3
United States
Connecticut DMHAS Problem Gambling Services and Bettor Choice Programs
Middletown, Connecticut, United States
Connecticut DMHAS Problem Gambling Services and Bettor Choice Programs
New Haven, Connecticut, United States
Yale University School of Medicine
New Haven, Connecticut, United States
Start Date
February 1, 2009
Primary Completion Date
February 1, 2016
Completion Date
January 1, 2017
Last Updated
October 13, 2017
NCT01528982
NCT01340274
NCT00685724
NCT01135264
NCT00580567
NCT00438776
Lead Sponsor
Yale University
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions